Fig. 4.
Overall (A) and recurrence-free (B) survival of patients with R0 status, R1 at transection margin, and R1 at mobilization margin after curative-intent resection for pancreatic neuroendocrine tumors.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.